EBM BLS: Adding tirzepatide to long-acting insulin is superior to adding mealtime insulin for type 2 diabetes mellitus

Authors

Venu Ganipisetti MD, Baystate HealthFollow

Author Department

Hospital Medicine; Medicine

Document Type

Article, Non peer-reviewed

Publication Date

8-2024

Recommended Citation

Fuest S, Ganipisetti V, Cunningham JM. EBM BLS: Adding tirzepatide to long-acting insulin is superior to adding mealtime insulin for type 2 diabetes mellitus. J Gen Intern Med. 2024 Aug 1. doi: 10.1007/s11606-024-08901-9. Epub ahead of print.

PMID

39090425